In-Depth Analysis Of Trocar Needle Manufacturing Processes

How Material Selection of Medical Stainless Steel to Electropolishing Ensures Quality for Reduced Core Biopsy Passes

https://www.cookmedical.com/products/ir_dtn_webds/

As Class II/III medical devices that directly contact human tissue and bear the responsibility of establishing biopsy channels, the manufacturing process of trocar needles directly determines the reliability of their clinical function of "reducing core biopsy passes." A typical production workflow comprises: material selection → laser cutting/deep hole drilling → obturator forming and tip grinding → cannula end chamfering and deburring → component fitting and sliding tests → electropolishing → cleaning and passivation → sterile packaging → comprehensive QC.

Material selection:​ Mainstream choices are ASTM F899-certified medical stainless steels 304 (light-use/single-channel) and 316L (VM series/multiple reuse or high corrosion-resistance requirements), with some high-end products using titanium alloy for the obturator to reduce weight and friction. 316L contains molybdenum for enhanced pitting corrosion resistance, making it suitable for scenarios involving repeated irrigation with blood clots or residual contrast agents. Raw materials must be accompanied by melt certificates (MTR) and biocompatibility declarations (ISO 10993).

Cutting and deep-hole machining:​ Cannulas are drawn from seamless thin-walled stainless steel tubes, with inner diameter tolerance typically at ±0.02 mm and roundness error <0.01 mm. Obturators are CNC-turned from solid bar stock and longitudinally polished to match the cannula inner cavity (general clearance 2–5 μm). Tips are formed using diamond grinding wheels in secondary/tertiary grinding into symmetrical triangular pyramids or dagger shapes; edge sharpness is inspected via optical projectors measuring R-angle <5 μm.

Fit and sliding:​ Reducing core passes requires the obturator to have a crisp, non-sticking insertion/withdrawal feel-100% insertion/extraction force testing is conducted in production (typical insertion force 3–8 N, slightly lower for withdrawal). Excessive tightness makes it difficult for the operator to quickly withdraw the stylet and establish the channel; excessive looseness allows tissue infiltration into the cannula. Some products apply diamond-like carbon (DLC) coating on the obturator surface to further reduce friction.

Electropolishing (EP):​ This critical surface treatment step removes microscopic burrs while forming a passivated chromium oxide film, achieving surface roughness Ra ≤ 0.2 μm and significantly reducing tissue adhesion. If the cannula inner wall is rough, tissue debris will snag during biopsy needle withdrawal, causing blockage and often forcing the operator to open a new channel and re-puncture (i.e., increasing core passes). Post-EP, cleanliness particulate tests and salt spray tests must be passed to verify corrosion resistance.

Quality control:​ Dimensions (diameter/length/fit clearance), sharpness (penetration force in simulated tissue surrogates), non-destructive testing (endoscopic inspection for inner wall cracks), and bioburden. Under the ISO 13485 system, first articles and process records are retained for each batch to ensure traceability. For purchasers, confirming whether the supplier holds ISO 13485 certification and CE/FDA 510(k) (where applicable) is the primary step in screening qualified trocar needle manufacturers.